Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Sugammadex for the Reversal of Moderate and Deep Rocuronium Induced Neuromuscular Block in Patients Pretreated With Magnesium Sulphate

NCT01440933 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT01440933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01440933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Sugammadex for the Reversal of Moderate and Deep Rocuronium Induced Neuromuscular Block in Patients Pretreated With Magnesium Sulphate
Lead sponsor
University Hospital, Geneva
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2011
Completion date
June 30, 2012
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular block